These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 36377677)
1. An update on maternal cardiac hemodynamics in fetal growth restriction and pre-eclampsia. Dall'Asta A; Minopoli M; Ramirez Zegarra R; Di Pasquo E; Ghi T J Clin Ultrasound; 2023 Feb; 51(2):265-272. PubMed ID: 36377677 [TBL] [Abstract][Full Text] [Related]
2. Relationship between cardiovascular function and fetal growth restriction in women with pre-eclampsia. Jia RZ; Liu XM; Wang X; Wu HQ Int J Gynaecol Obstet; 2010 Jul; 110(1):61-3. PubMed ID: 20362985 [TBL] [Abstract][Full Text] [Related]
3. Fetal Growth Restriction: Does an Integrated Maternal Hemodynamic-Placental Model Fit Better? Mecacci F; Avagliano L; Lisi F; Clemenza S; Serena C; Vannuccini S; Rambaldi MP; Simeone S; Ottanelli S; Petraglia F Reprod Sci; 2021 Sep; 28(9):2422-2435. PubMed ID: 33211274 [TBL] [Abstract][Full Text] [Related]
4. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies. Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal maternal hemodynamics in pregnancies affected by fetal growth restriction. Stott D; Papastefanou I; Paraschiv D; Clark K; Kametas NA Ultrasound Obstet Gynecol; 2017 Jun; 49(6):761-768. PubMed ID: 27854379 [TBL] [Abstract][Full Text] [Related]
6. Placental Abnormalities and Placenta-Related Complications Following Kong F; Fu Y; Shi H; Li R; Zhao Y; Wang Y; Qiao J Front Endocrinol (Lausanne); 2022; 13():924070. PubMed ID: 35846290 [TBL] [Abstract][Full Text] [Related]
7. Nitric oxide metabolism in the human placenta during aberrant maternal inflammation. Mukosera GT; Clark TC; Ngo L; Liu T; Schroeder H; Power GG; Yellon SM; Parast MM; Blood AB J Physiol; 2020 Jun; 598(11):2223-2241. PubMed ID: 32118291 [TBL] [Abstract][Full Text] [Related]
9. Maternal hemodynamics in normal pregnancy and in pregnancy affected by pre-eclampsia. Stott D; Nzelu O; Nicolaides KH; Kametas NA Ultrasound Obstet Gynecol; 2018 Sep; 52(3):359-364. PubMed ID: 28796394 [TBL] [Abstract][Full Text] [Related]
10. Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial. Ling HZ; Guy GP; Bisquera A; Poon LC; Nicolaides KH; Kametas NA Ultrasound Obstet Gynecol; 2019 Jul; 54(1):51-57. PubMed ID: 30246326 [TBL] [Abstract][Full Text] [Related]
11. Abnormal placental CD8 Lager S; Sovio U; Eddershaw E; van der Linden MW; Yazar C; Cook E; Happerfield L; Jessop FA; Sebire NJ; Charnock-Jones DS; Smith GCS J Physiol; 2020 Dec; 598(23):5555-5571. PubMed ID: 32886802 [TBL] [Abstract][Full Text] [Related]
12. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction. Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598 [TBL] [Abstract][Full Text] [Related]
13. Preeclampsia has two phenotypes which require different treatment strategies. Masini G; Foo LF; Tay J; Wilkinson IB; Valensise H; Gyselaers W; Lees CC Am J Obstet Gynecol; 2022 Feb; 226(2S):S1006-S1018. PubMed ID: 34774281 [TBL] [Abstract][Full Text] [Related]
14. Maternal subclinical vascular changes in fetal growth restriction with and without pre-eclampsia. Stergiotou I; Bijnens B; Cruz-Lemini M; Figueras F; Gratacos E; Crispi F Ultrasound Obstet Gynecol; 2015 Dec; 46(6):706-12. PubMed ID: 25678131 [TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction. Zhu J; Zhong M; Pang Z; Yu Y Early Hum Dev; 2014 Oct; 90(10):657-64. PubMed ID: 25194834 [TBL] [Abstract][Full Text] [Related]
16. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array. Yagel S; Cohen SM; Goldman-Wohl D Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272 [TBL] [Abstract][Full Text] [Related]
17. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Nishizawa H; Ota S; Suzuki M; Kato T; Sekiya T; Kurahashi H; Udagawa Y Reprod Biol Endocrinol; 2011 Aug; 9():107. PubMed ID: 21810232 [TBL] [Abstract][Full Text] [Related]
18. Maternal hemodynamic assessment by USCOM Montaguti E; Youssef A; Cavalera M; Dodaro MG; Cofano M; Fiorentini M; Pellegrino A; Pilu G J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5580-5586. PubMed ID: 33586584 [TBL] [Abstract][Full Text] [Related]
19. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus? Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215 [TBL] [Abstract][Full Text] [Related]
20. Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function. Tay J; Masini G; McEniery CM; Giussani DA; Shaw CJ; Wilkinson IB; Bennett PR; Lees CC Am J Obstet Gynecol; 2019 Jan; 220(1):96.e1-96.e8. PubMed ID: 30243605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]